Download FREE Report Sample
Download Free sampleMifepristone is a progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua.?
Mifepristone Market contains market size and forecasts of Mifepristone in global, including the following market information:
Global Mifepristone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mifepristone Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Mifepristone companies in 2021 (%)
The global Mifepristone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mifepristone include Merck Serono, Pfizer, GenBioPro, Linepharma International, Monsanto/Searle, Zhejiang Xianju Pharmaceutical, Hubei Gedian Renfu Pharmaceutical, Shanghai Xinhualian Pharmaceutical and Huarun Zizhu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mifepristone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mifepristone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Mifepristone Market Segment Percentages, by Type, 2021 (%)
Tablets
(Soft) Capsule
Other
Global Mifepristone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Mifepristone Market Segment Percentages, by Application, 2021 (%)
Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
Pregnant,
Urged By The Check
Intrauterine Induction Of Labor After Fetal Death
Gynecologic Surgery
Other
Global Mifepristone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Mifepristone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mifepristone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mifepristone revenues share in global market, 2021 (%)
Key companies Mifepristone sales in global market, 2017-2022 (Estimated), (KG)
Key companies Mifepristone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Serono
Pfizer
GenBioPro
Linepharma International
Monsanto/Searle
Zhejiang Xianju Pharmaceutical
Hubei Gedian Renfu Pharmaceutical
Shanghai Xinhualian Pharmaceutical
Huarun Zizhu Pharmaceutical
Guangzhou Longsheng Pharmaceutical
Shenzhen Zifu Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
